These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7501433)

  • 1. [Role of endogenous biologically active substances in the regulation of pulmonary circulation in patients with hypervolemic congenital heart defects].
    Gerasimov NM; Guliamov DS; Nam LN
    Patol Fiziol Eksp Ter; 1995; (3):31-3. PubMed ID: 7501433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary hypertension in congenital heart defects in childhood].
    Bühlmeyer K
    Bibl Paediatr; 1967; 85():1-89. PubMed ID: 5590825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biologically active substances in patients with hypervolemic congenital heart defects undergoing general multicomponent anesthesia].
    Gerasimov NM; Guliamov DS; Karimova TZ; Belova OA; Ivanova LS; Nam LN
    Anesteziol Reanimatol; 1994; (2):19-22. PubMed ID: 8059988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated T wave inversion in the precordial ECG in congenital heart diseases.
    Poveda Sierra JJ; Medrano GA; Ochoteco A; Pajarón A; Marín-Huerta E
    Arch Inst Cardiol Mex; 1974; 44(5):725-35. PubMed ID: 4413999
    [No Abstract]   [Full Text] [Related]  

  • 5. The pulmonary circulation in congenital heart disease. II. Pulmonary hypertension.
    Haworth SG
    Herz; 1978 Apr; 3(2):138-42. PubMed ID: 721042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular disease in acquired and congenital heart disease.
    Dexter L
    Arch Intern Med; 1979 Aug; 139(8):922-8. PubMed ID: 464710
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some pathomorphological aspects of pulmonary hypertension in congenital heart diseases with increased pulmonary circulation].
    Korotkov AA; Revzis MG
    Kardiologiia; 1972 Feb; 12(2):66-71. PubMed ID: 4635552
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biologically active substances during treatment of pulmonary hypertension with ATP infusions immediately after general anesthesia and surgery of hypervolemic congenital heart defects].
    Gerasimov NM; Guliamov DS; Karimova TZ; Belova OA; Ivanova LS; Nam LN
    Anesteziol Reanimatol; 1994; (3):14-7. PubMed ID: 8080119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary mechanics and small airways in patent ductus arteriosus and interventricular communication, in relation to pulmonary arterial flow and pressure].
    Martínez-Guerra ML; Fernández-Bonetti P; Peraza C; Lupi-Herrera E
    Arch Inst Cardiol Mex; 1982; 52(4):349-56. PubMed ID: 7138137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Palliative operation for congenital heart disease with increased pulmonary blood flow during neonates and infancy].
    Shimada M; Tsunemoto M; Ota Y; Sasaki T; Masaki H; Hojo H; Naganuma M; Koike K; Takano Y
    Kyobu Geka; 1984 Feb; 37(2):148-53. PubMed ID: 6201641
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus].
    Hruda J; Samánek M; First T; Vorísková M; Skovránek J
    Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo pressure-radius relationships of the pulmonary artery in children with congenital heart disease.
    Jarmakani JM; Graham TP; Benson DW; Canent RV; Greenfield JC
    Circulation; 1971 Apr; 43(4):585-92. PubMed ID: 5573389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary hypertension in the surgery of congenital heart defects].
    Burakovskiĭ VI; Fal'kovskiĭ GE; Plotnikova LR; Gordonova MI; Gorchakova AI
    Ter Arkh; 1983; 55(1):81-6. PubMed ID: 6836533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Elasticity of the lungs under physical loading in congenital heart defect patients before and after surgery].
    Gritsenko VI; Gavrilenko VI; Eremeeva MI; Mochalov OIu
    Vestn Khir Im I I Grek; 1982 Mar; 128(3):53-9. PubMed ID: 7080391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of reserve possibilities of the cardiorespiratory system and pulmonary perfusion after surgical correction of congenital heart defects with arteriovenous blood output].
    Volovoĭ VL; Khodzhibekov MKh; Gafurov FKh; Abdumadzhidov KhA
    Vestn Khir Im I I Grek; 1990 Aug; 145(8):3-5. PubMed ID: 2177258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of circulating central blood volume and of lung transit time by radiocardiography in left-right shunts].
    Di Matteo J; Picard R; Vacheron A; Bousquet O; Kellershohn C; de Vernejoul P
    Arch Mal Coeur Vaiss; 1969 Feb; 62(2):160-72. PubMed ID: 4983185
    [No Abstract]   [Full Text] [Related]  

  • 17. Stenting the patent arterial duct to increase pulmonary blood flow.
    Mahesh K; Kannan BR; Vaidyanathan B; Kamath P; Anil SR; Kumar RK
    Indian Heart J; 2005; 57(6):704-8. PubMed ID: 16521642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late results following surgical treatment of congenital heart disease associated with hypertension of the lesser circulation].
    Uglov FG; Gritsenko VV
    Grudn Khir; 1977; (3):33-8. PubMed ID: 873307
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiopathology of pulmonary circulation in congenital heart diseases with right-left shunt].
    Pellegrini G
    Atti Soc Ital Cardiol; 1964; 3():36-40. PubMed ID: 5861826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stages of heart defects as a reflection of the compensation--para-compensation development].
    Meshalkin EN; Litasova EE; Vlasov IuA; Okuneva GN; Chasovskikh GG
    Vestn Akad Med Nauk SSSR; 1991; (7):50-4. PubMed ID: 1838225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.